Advertisement
Screener

CRONOS GROUP INC. (CRON) Unrealized Gain (Loss) on Investments

2.2 / 5 stars · 30/68 Roast Me

CRONOS GROUP INC. Unrealized Gain (Loss) on Investments

CRONOS GROUP INC. (CRON) reported Unrealized Gain (Loss) on Investments of -$615.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-08-06

  • CRONOS GROUP INC. unrealized gain (loss) on investments for the quarter ending 2026-06-30 was -$615.00K.
  • CRONOS GROUP INC. unrealized gain (loss) on investments for the quarter ending 2026-03-31 was -$2.48M.
  • CRONOS GROUP INC. unrealized gain (loss) on investments for the quarter ending 2025-12-31 was -$3.93M, a 1599.24% decline year-over-year.
  • CRONOS GROUP INC. unrealized gain (loss) on investments for the quarter ending 2025-09-30 was $4.18M.
  • CRONOS GROUP INC. unrealized gain (loss) on investments for fiscal 2025 was -$446.00K.
  • CRONOS GROUP INC. unrealized gain (loss) on investments for fiscal 2024 was -$6.21M.
  • CRONOS GROUP INC. unrealized gain (loss) on investments for fiscal 2023 was -$12.10M, a 182.07% decline from fiscal 2022.
  • CRONOS GROUP INC. unrealized gain (loss) on investments for fiscal 2022 was $14.74M.
Period endUnrealized Gain (Loss) on Investments 3 monthUnrealized Gain (Loss) on Investments 6 monthUnrealized Gain (Loss) on Investments 9 monthUnrealized Gain (Loss) on Investments 12 month
2026-06-30-$615.00K
10-Q · filed 2026-08-06
-$3.10M
10-Q · filed 2026-08-06
-$7.03M
derived: sum of 3 quarters · filed 2026-08-06
-$2.85M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$2.48M
10-Q · filed 2026-05-11
-$6.41M
derived: sum of 2 quarters · filed 2026-05-11
-$2.23M
derived: sum of 3 quarters · filed 2026-05-11
-$2.86M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$3.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$254.00K
derived: sum of 2 quarters · filed 2026-02-26
-$378.00K
derived: sum of 3 quarters · filed 2026-08-06
-$446.00K
10-K · filed 2026-02-26
2025-09-30$4.18M
10-Q · filed 2025-11-06
$3.55M
derived: sum of 2 quarters · filed 2026-08-06
$3.48M
10-Q · filed 2025-11-06
$3.74M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$632.00K
10-Q · filed 2026-08-06
-$700.00K
10-Q · filed 2026-08-06
-$438.00K
derived: sum of 3 quarters · filed 2026-08-06
-$809.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$68.00K
10-Q · filed 2026-05-11
$194.00K
derived: sum of 2 quarters · filed 2026-05-11
-$177.00K
derived: sum of 3 quarters · filed 2026-05-11
-$3.93M
derived: sum of 4 quarters · filed 2026-05-11
2024-12-31$262.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$109.00K
derived: sum of 2 quarters · filed 2026-02-26
-$3.86M
derived: sum of 3 quarters · filed 2026-02-26
-$6.21M
10-K · filed 2026-02-26
2024-09-30-$371.00K
10-Q · filed 2025-11-06
-$4.13M
derived: sum of 2 quarters · filed 2025-11-06
-$6.47M
10-Q · filed 2025-11-06
-$10.63M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30-$3.75M
10-Q · filed 2025-08-07
-$6.10M
10-Q · filed 2025-08-07
-$10.26M
derived: sum of 3 quarters · filed 2025-08-07
-$15.46M
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31-$2.34M
10-Q · filed 2025-05-08
-$6.50M
derived: sum of 2 quarters · filed 2025-05-08
-$11.71M
derived: sum of 3 quarters · filed 2025-05-08
-$6.51M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31-$4.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$9.37M
derived: sum of 2 quarters · filed 2025-02-27
-$4.17M
derived: sum of 3 quarters · filed 2025-02-27
-$12.10M
10-K · filed 2025-02-27
2023-09-30-$5.20M
10-Q · filed 2024-11-12
-$10.00K
derived: sum of 2 quarters · filed 2024-11-12
-$7.93M
10-Q · filed 2024-11-12
-$12.31M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30$5.19M
10-Q · filed 2024-08-08
-$2.73M
10-Q · filed 2024-08-08
-$7.10M
derived: sum of 3 quarters · filed 2024-08-08
$10.01M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$7.92M
10-Q · filed 2024-05-09
-$12.30M
derived: sum of 2 quarters · filed 2024-05-09
$4.82M
derived: sum of 3 quarters · filed 2024-05-09
$2.62M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31-$4.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$12.74M
derived: sum of 2 quarters · filed 2024-02-29
$10.54M
derived: sum of 3 quarters · filed 2024-02-29
$14.74M
10-K · filed 2024-02-29
2022-09-30$17.12M
10-Q · filed 2023-11-08
$14.92M
derived: sum of 2 quarters · filed 2023-11-08
$19.11M
10-Q · filed 2023-11-08
2022-06-30-$2.20M
10-Q · filed 2023-08-08
$2.00M
10-Q · filed 2023-08-08
2022-03-31$4.20M
10-Q · filed 2023-05-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87